Delivery Order SPE2DB24D8003-SPE2DB25FJUCW
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,461.76 firm-fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a completion date of February 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT...
This is a $2,157.72 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on November 25, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,563,714,305 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $2,237.18 and a completion date of February 21, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award...
This is a $1,979.66 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of 4562235206 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $3,155.20 and a period of performance through October 31, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Vyvanse 70 mg capsules, a pharmaceutical product. The contract has a ceiling value of $2,942.04 and an ultimate completion date of April 30, 2025. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC)...
This federal contract award, with a ceiling value of $2,122.33, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) with a maximum value of $999,999,999.00 and a performance period through December 31, 2025. The contract is for the delivery of 4,562,763,308 units of Vyvanse 30 mg capsules, a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 100 units of the prescription medication Vyvanse 50 mg capsules, with a total ceiling value of $1,328.62 and a performance period through July 24, 2024. The contract is not designated as a set-aside and is part of Dakota Drug's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Vyvanse 10mg capsules, a prescription medication, with a ceiling value of $2,511.86 and a period of performance through February 19, 2025. The contract is not set aside and is a Firm Fixed Price type. Dakota Drug, Inc. is the prime contractor and no subcontractors are mentioned. This contract is likely part of the...
The Defense Logistics Agency (DLA) awarded a $1,184.36 firm fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication. This delivery order falls under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical...